Dar Al Dawa Development and Investment Co. Ltd. (ASE:DADI)

Jordan flag Jordan · Delayed Price · Currency is JOD
1.170
+0.030 (2.63%)
At close: Aug 10, 2025
-10.00%
Market Cap 43.40M
Revenue (ttm) 82.70M
Net Income (ttm) 4.14M
Shares Out 35.00M
EPS (ttm) 0.12
PE Ratio 10.45
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 86,168
Average Volume 24,120
Open 1.150
Previous Close 1.140
Day's Range 1.150 - 1.190
52-Week Range 1.100 - 1.310
Beta 0.24
RSI 76.24
Earnings Date Jul 31, 2025

About ASE:DADI

Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical and consumer healthcare products in Levant, Gulf and Yemen, the Middle East, Africa, Europe, and Asia. It operates through Medicine; and Infants’ Cereals and Milk Formula segments. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, urology, respiratory, gastrointestinal, analgesic and musculoskeletal, central nervous system, gynecology, dermatolog... [Read more]

Industry Pharmaceutical Preparations
Founded 1975
Employees 1,111
Stock Exchange Amman Stock Exchange
Ticker Symbol DADI
Full Company Profile

Financial Performance

In 2024, ASE:DADI's revenue was 81.18 million, an increase of 8.42% compared to the previous year's 74.88 million. Earnings were 3.59 million, an increase of 13.41%.

Financial Statements

News

There is no news available yet.